Mark J. Ott
Impact in
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- Polyomavirus and related diseases
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 11
- Vascular Tumors and Angiosarcomas 4
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Barbara J. BallermannJean-Pierre E. N. PierieAlona MuzikanskyDianne M. FinkelsteinChristopher G. WillettG. Petur NielsenKenneth K. TanabeWiley W. Souba
- Journals
- Annals of Surgical Oncology (3 papers)Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Surgery (2 papers)Otolaryngology (2 papers)
- Partner nations
- United StatesNetherlandsSpain
In The Last Decade
Mark J. Ott
32 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Oncology 758
- Pulmonary and Respiratory Medicine 543
- Dermatology 136
- Cardiology and Cardiovascular Medicine 254
- Neurology 162
Countries citing papers authored by Mark J. Ott
This map shows the geographic impact of Mark J. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Ott more than expected).
Fields of papers citing papers by Mark J. Ott
This network shows the impact of papers produced by Mark J. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Ott. The network helps show where Mark J. Ott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark J. Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2016 | 18 | |
| 3 | Who Renews? Who Leaves? Identifying Customer Churn in a Telecom Company Using Big Data Techniques | 2016 | 1 |
| 4 | 2011 | 39 | |
| 5 | 2009 | 47 | |
| 6 | 2006 | 53 | |
| 7 | 2005 | 15 | |
| 8 | 2003 | 108 | |
| 9 | 2002 | 148 | |
| 10 | 2002 | 92 | |
| 11 | 2002 | 8 | |
| 12 | 2001 | 62 | |
| 13 | 2001 | 20 | |
| 14 | 2001 | 158 | |
| 15 | 2000 | 7 | |
| 16 | 1999 | 204 | |
| 17 | 1995 | 47 | |
| 18 | 1995 | 43 | |
| 19 | 1995 | 82 | |
| 20 | 1988 | 36 |
About Mark J. Ott
Mark J. Ott is a scholar working on Dermatology, Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Neurology, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Vascular Tumors and Angiosarcomas (4 papers), Cardiac tumors and thrombi (4 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Aortic Disease and Treatment Approaches (3 papers), Photodynamic Therapy Research Studies (3 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Oncology (758 citations), Pulmonary and Respiratory Medicine (543 citations), Dermatology (136 citations), Cardiology and Cardiovascular Medicine (254 citations) and Neurology (162 citations). Mark J. Ott has collaborated with scholars based in United States, Netherlands and Spain. Frequent co-authors include Barbara J. Ballermann, Jean-Pierre E. N. Pierie, Alona Muzikansky, Dianne M. Finkelstein, Christopher G. Willett, G. Petur Nielsen, Kenneth K. Tanabe, Wiley W. Souba, Umar Choudry and Susanne H. Estourgie. Their work appears in journals such as Annals of Surgical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, Surgery and Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.